Stocks To Buy Today: Sun Pharma, Paytm, HDFC Life Among Others
For Friday's trading session, several analysts have recommended key stocks for potential investment. Milan Vaishnav, Founder and Technical Analyst at Gemstone Equity Research, suggests buying Sun Pharma and Paytm. Rajesh Palviya, SVP, Technical and Derivatives Research at Axis Securities, recommends HDFC Life and Apollo Tyres. Chandan Taparia, Head of Technical & Derivatives Research at MOFSL, advises investing in Bharti Airtel. Each stock has specific target prices and stop-loss levels to guide investors.
Sun Pharma
Milan Vaishnav recommends buying Sun Pharmaceutical Industries Ltd. above Rs 1,830, with a target price of Rs 1,925 and a stop-loss at Rs 1,780. The stock is currently trading at Rs 1,821, making it a potential buy for investors looking for growth in the pharmaceutical sector.
Out of 42 analysts tracking the company, 34 maintain a 'buy' rating, five recommend a 'hold,' and three suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 13%.
Paytm
One 97 Communications Ltd. is another stock recommended by Vaishnav. Investors are advised to buy above Rs 865, aiming for a target price of Rs 930, with a stop-loss at Rs 830. The stock is currently priced at ₹861, presenting an opportunity in the digital payments space.
Out of 19 analysts tracking the company, nine maintain a 'buy' rating, six recommend a 'hold,' and four suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an downside of 2.2%.
HDFC Life
Rajesh Palviya suggests buying HDFC Life Insurance Company Ltd. at Rs 743, targeting Rs 768, with a stop-loss at Rs 728. This makes HDFC Life a viable option for those interested in the insurance sector.
Out of 36 analysts tracking the company, 29 maintain a 'buy' rating and seven recommend a 'hold', according to Bloomberg data. The average 12-month consensus price target implies an upside of 9.4%.
Apollo Tyres
Apollo Tyres Ltd. is also recommended by Palviya for purchase at Rs 471, with a target of Rs 486 and a stop-loss at Rs 462. Out of 27 analysts tracking the company, 19 maintain a 'buy' rating, three recommend a 'hold,' and five suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 4%.
Bharti Airtel
Chandan Taparia advises buying Bharti Airtel Ltd. at its current market price of Rs 1,864, with a target price of Rs 1,975 and a stop-loss at Rs 1,805.
Out of 35 analysts tracking the company, 30 maintain a 'buy' rating, three recommend a 'hold,' and two suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 1.5%.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
